10:58 IST
BSE
Other Announcement
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ended March 31, 2026, in compliance with SEBI regulations.
Bal Pharma Ltd
- Share price
- ₹97.50
- Market cap
- ₹155.2 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 21.5×Sector 47.4×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Annual General Meeting 7Other Announcement 4Capital Structure Change 3Management Change 2Price Movement Clarification 1Merger & Restructuring 1Financial Results 1Dividend 1Board Meeting Date 1Annual Report 1
Time
4 announcements with these filters
13:34 IST
BSE
Other Announcement
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ending December 31, 2025. This disclosure provides details on share distribution among promoters and public.
17:13 IST
BSE
Other Announcement
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, as required by SEBI regulations.
12:44 IST
BSE
Other Announcement
Bal Pharma Other Announcement
BAL PHARMA Ltd filed its quarterly shareholding pattern for Q2 FY2026. The filing details promoter and shareholder holdings without any monetary transaction.